LS Investment Advisors’s Merck MRK Stock Holding History

LS Investment Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.88M	Sell	22,418 -8,755	-28%	-$1.02M	0.39%	50
2026 Q1	$3.75M	Sell	31,173 -2,760	-8%	-$319K	0.56%	46
2025 Q4	$3.57M	Buy	33,933 +850	+3%	+$79.8K	0.5%	40
2025 Q3	$2.78M	Sell	33,083 -2,368	-7%	-$195K	0.39%	44
2025 Q2	$2.81M	Buy	35,451 +2,995	+9%	+$238K	0.41%	45
2025 Q1	$2.91M	Buy	32,456 +4,780	+17%	+$446K	0.45%	46
2024 Q4	$2.75M	Sell	27,676 -29,966	-52%	-$3.09M	0.4%	47
2024 Q3	$6.55M	Buy	57,642 +189	+0.3%	+$22.5K	0.97%	37
2024 Q2	$7.11M	Buy	57,453 +340	+0.6%	+$43.8K	1.11%	34
2024 Q1	$7.54M	Buy	57,113 +6,863	+14%	+$846K	1.2%	32
2023 Q4	$5.48M	Buy	50,250 +828	+2%	+$85.9K	0.95%	36
2023 Q3	$5.09M	Sell	49,422 -123	-0.2%	-$13.3K	0.96%	36
2023 Q2	$5.72M	Buy	49,545 +6,619	+15%	+$752K	1%	38
2023 Q1	$4.57M	Buy	42,926 +12,020	+39%	+$1.3M	0.85%	39
2022 Q4	$3.43M	Buy	30,906 +4,434	+17%	+$453K	0.67%	40
2022 Q3	$2.28M	Buy	26,472 +5	+0%	+$446	0.46%	49
2022 Q2	$2.41M	Buy	26,467 +605	+2%	+$53.6K	0.45%	49
2022 Q1	$2.12M	Sell	25,862 -880	-3%	-$69.4K	0.34%	53
2021 Q4	$2.05M	Sell	26,742 -7,273	-21%	-$579K	0.31%	56
2021 Q3	$2.56M	Hold	34,015	–	–	0.33%	53
2021 Q2	$2.65M	Sell	34,015 -42,314	-55%	-$3.15M	0.34%	54
2021 Q1	$5.62M	Sell	76,329 -12,299	-14%	-$907K	0.31%	81
2020 Q4	$6.92M	Buy	88,628 +1,669	+2%	+$128K	0.36%	68
2020 Q3	$6.88M	Buy	86,959 +2,946	+4%	+$231K	0.39%	62
2020 Q2	$6.2M	Buy	84,013 +10,654	+15%	+$802K	0.39%	60
2020 Q1	$5.39M	Sell	73,359 -8,734	-11%	-$686K	0.39%	62
2019 Q4	$7.12M	Sell	82,093 -30	-0%	-$2.46K	0.38%	58
2019 Q3	$6.6M	Buy	82,123 +1,113	+1%	+$89.2K	0.39%	62
2019 Q2	$6.48M	Buy	81,010 +348	+0.4%	+$26.6K	0.39%	58
2019 Q1	$6.4M	Sell	80,662 -638	-0.8%	-$47.7K	0.4%	55
2018 Q4	$5.93M	Sell	81,300 -7,858	-9%	-$555K	0.41%	57
2018 Q3	$6.04M	Buy	89,158 +5,640	+7%	+$359K	0.35%	66
2018 Q2	$4.84M	Sell	83,518 -3,292	-4%	-$186K	0.29%	72
2018 Q1	$4.51M	Sell	86,810 -252	-0.3%	-$13.6K	0.27%	81
2017 Q4	$4.67M	Buy	87,062 +1,631	+2%	+$90.4K	0.27%	82
2017 Q3	$5.22M	Sell	85,431 -437	-0.5%	-$26.5K	0.31%	68
2017 Q2	$5.25M	Buy	85,868 +3,584	+4%	+$218K	0.32%	65
2017 Q1	$4.99M	Sell	82,284 -2,073	-2%	-$126K	0.32%	66
2016 Q4	$4.74M	Sell	84,357 -17,958	-18%	-$1.05M	0.33%	59
2016 Q3	$6.09M	Sell	102,315 -3,731	-4%	-$218K	0.45%	48
2016 Q2	$5.83M	Buy	106,046 +4,696	+5%	+$250K	0.4%	54
2016 Q1	$5.12M	Buy	101,350 +1,267	+1%	+$62.1K	0.38%	57
2015 Q4	$5.04M	Buy	100,083 +17,063	+21%	+$860K	0.39%	56
2015 Q3	$3.91M	Buy	83,020 +5,337	+7%	+$284K	0.31%	64
2015 Q2	$4.22M	Buy	77,683 +2,418	+3%	+$136K	0.31%	67
2015 Q1	$4.13M	Buy	75,265 +11,606	+18%	+$657K	0.32%	73
2014 Q4	$3.45M	Buy	63,659 +3,478	+6%	+$194K	0.28%	74
2014 Q3	$3.4M	Sell	60,181 -1,048	-2%	-$58.8K	0.29%	71
2014 Q2	$3.38M	Sell	61,229 -4,093	-6%	-$223K	0.29%	75
2014 Q1	$3.54M	Sell	65,322 -583	-0.9%	-$30.2K	0.29%	78
2013 Q4	$3.15M	Buy	65,905 +13,761	+26%	+$629K	0.28%	81
2013 Q3	$2.37M	Buy	52,144 +2,179	+4%	+$99.5K	0.28%	81
2013 Q2	$2.21M	Buy	+49,965	New	+$2.23M	0.28%	74

Other funds holding MRK

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

LS Investment Advisors's MRK Position: Q2 2026 in Review

LS Investment Advisors reduced its Merck (MRK) stake by 28% in Q2 2026, selling an estimated $1.02M and leaving 22,418 shares worth $2.88M. The position accounts for 0.39% of the portfolio, ranked #50.

LS Investment Advisors first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.54M in Q1 2024. 1,056 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

LS Investment Advisors held 22,418 shares of Merck worth $2.88M as of Q2 2026.
LS Investment Advisors sold 8,755 Merck shares in Q2 2026, an estimated $1.02M.
Merck made up 0.39% of LS Investment Advisors's portfolio in Q2 2026, its #50 holding.
LS Investment Advisors first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
LS Investment Advisors's Merck position peaked at $7.54M in Q1 2024.
1,056 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on LS Investment Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.